These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7509255)

  • 21. Surgical treatment of patients with stages I and II nonseminomatous testicular cancer.
    Fraley EE; Narayan P; Vogelzang NJ; Kennedy BJ; Lange PH
    J Urol; 1985 Jul; 134(1):70-3. PubMed ID: 2409301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study.
    Tandstad T; Cohn-Cedermark G; Dahl O; Stierner U; Cavallin-Stahl E; Bremnes RM; Klepp O
    Ann Oncol; 2010 Sep; 21(9):1858-1863. PubMed ID: 20142410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy.
    Hollender A; Stenwig EA; Ous S; Fosså SD
    Eur Urol; 1997; 31(2):141-7. PubMed ID: 9076455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
    Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
    J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage i nonseminomatous germ cell tumor.
    Studer UE; Burkhard FC; Sonntag RW
    J Urol; 2000 Jun; 163(6):1785-7. PubMed ID: 10799182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of adjuvant chemotherapy in testicular cancer.
    Bernstein JI; Freiha F; Breeden J; Torti FM
    Cancer; 1987 Oct; 60(8):1729-30. PubMed ID: 2443231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
    Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
    Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.
    Cullen MH; Stenning SP; Parkinson MC; Fossa SD; Kaye SB; Horwich AH; Harland SJ; Williams MV; Jakes R
    J Clin Oncol; 1996 Apr; 14(4):1106-13. PubMed ID: 8648364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
    Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemotherapy in resected stage-II nonseminomatous germ cell tumors of testis. In which cases is it necessary?
    Pizzocaro G; Piva L; Salvioni R; Pasi M; Pilotti S; Monfardini S
    Eur Urol; 1984; 10(3):151-8. PubMed ID: 6327314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.
    Chevreau C; Mazerolles C; Soulié M; Gaspard MH; Mourey L; Bujan L; Plante P; Rischmann P; Bachaud JM; Malavaud B
    Eur Urol; 2004 Aug; 46(2):209-14; discussion 214-5. PubMed ID: 15245815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis.
    Pizzocaro G; Monfardini S
    J Urol; 1984 Apr; 131(4):677-80. PubMed ID: 6200611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors.
    Kondagunta GV; Motzer RJ
    Semin Urol Oncol; 2002 Nov; 20(4):239-43. PubMed ID: 12489056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
    Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy.
    Gelderman WA; Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Van der Heide JN; Mulder NH; Marrink J; De Bruyn HW; Oldhoff J
    J Surg Oncol; 1988 Aug; 38(4):227-32. PubMed ID: 2457771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience.
    Behnia M; Foster R; Einhorn LH; Donohue J; Nichols CR
    Eur J Cancer; 2000 Mar; 36(4):472-5. PubMed ID: 10717522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant germ cell tumors in childhood.
    Nair R; Pai SK; Saikia TK; Nair CN; Kurkure PA; Gopal R; Sampat MS; Advani SH
    J Surg Oncol; 1994 Jul; 56(3):186-90. PubMed ID: 7518019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.